Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 299

Cited In for PubMed (Select 11780111)

1.

TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma.

Rebbani K, Marchio A, Ezzikouri S, Afifi R, Kandil M, Bahri O, Triki H, Essaid El Feydi A, Dejean A, Benjelloun S, Pineau P.

Mol Cancer. 2015 Apr 2;14(1):74. doi: 10.1186/s12943-015-0340-2.

2.
3.

Modelling the p53/p66Shc Aging Pathway in the Shortest Living Vertebrate Nothobranchius Furzeri.

Priami C, De Michele G, Cotelli F, Cellerino A, Giorgio M, Pelicci PG, Migliaccio E.

Aging Dis. 2015 Mar 10;6(2):95-108. doi: 10.14336/AD.2014.0228. eCollection 2015 Mar. Review.

4.

Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo.

He X, Liu F, Yan J, Zhang Y, Yan J, Shang H, Dou Q, Zhao Q, Song Y.

Sci Rep. 2015 Mar 3;5:8705. doi: 10.1038/srep08705.

5.

Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice.

Gogiraju R, Xu X, Bochenek ML, Steinbrecher JH, Lehnart SE, Wenzel P, Kessel M, Zeisberg EM, Dobbelstein M, Schäfer K.

J Am Heart Assoc. 2015 Feb 24;4(2). pii: e001770. doi: 10.1161/JAHA.115.001770.

6.

INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform.

Tian X, Azpurua J, Ke Z, Augereau A, Zhang ZD, Vijg J, Gladyshev VN, Gorbunova V, Seluanov A.

Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1053-8. doi: 10.1073/pnas.1418203112. Epub 2014 Dec 30.

PMID:
25550505
7.

p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells.

He Y, de Castro LF, Shin MH, Dubois W, Yang HH, Jiang S, Mishra PJ, Ren L, Gou H, Lal A, Khanna C, Merlino G, Lee M, Robey PG, Huang J.

Stem Cells. 2015 Apr;33(4):1304-19. doi: 10.1002/stem.1925.

PMID:
25524638
8.

Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors.

Zhang J, Xu E, Ren C, Yan W, Zhang M, Chen M, Cardiff RD, Imai DM, Wisner E, Chen X.

Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18637-42. doi: 10.1073/pnas.1415607112. Epub 2014 Dec 15.

PMID:
25512531
9.

Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors.

Di Renzo L, Gratteri S, Sarlo F, Cabibbo A, Colica C, De Lorenzo A.

Dis Markers. 2014;2014:743634. doi: 10.1155/2014/743634. Epub 2014 Oct 13.

10.

Palladium and platinum nanoparticles attenuate aging-like skin atrophy via antioxidant activity in mice.

Shibuya S, Ozawa Y, Watanabe K, Izuo N, Toda T, Yokote K, Shimizu T.

PLoS One. 2014 Oct 15;9(10):e109288. doi: 10.1371/journal.pone.0109288. eCollection 2014.

11.

Development of the fetal bone marrow niche and regulation of HSC quiescence and homing ability by emerging osteolineage cells.

Coşkun S, Chao H, Vasavada H, Heydari K, Gonzales N, Zhou X, de Crombrugghe B, Hirschi KK.

Cell Rep. 2014 Oct 23;9(2):581-90. doi: 10.1016/j.celrep.2014.09.013. Epub 2014 Oct 9.

12.

Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells.

Lin YC, Murayama Y, Hashimoto K, Nakamura Y, Lin CS, Yokoyama KK, Saito S.

Stem Cell Res Ther. 2014;5(2):58.

13.

Limiting the power of p53 through the ubiquitin proteasome pathway.

Pant V, Lozano G.

Genes Dev. 2014 Aug 15;28(16):1739-51. doi: 10.1101/gad.247452.114. Review.

14.

Inappropriate p53 activation during development induces features of CHARGE syndrome.

Van Nostrand JL, Brady CA, Jung H, Fuentes DR, Kozak MM, Johnson TM, Lin CY, Lin CJ, Swiderski DL, Vogel H, Bernstein JA, Attié-Bitach T, Chang CP, Wysocka J, Martin DM, Attardi LD.

Nature. 2014 Oct 9;514(7521):228-32. doi: 10.1038/nature13585. Epub 2014 Aug 3.

15.

Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence.

Tran D, Bergholz J, Zhang H, He H, Wang Y, Zhang Y, Li Q, Kirkland JL, Xiao ZX.

Aging Cell. 2014 Aug;13(4):669-78. doi: 10.1111/acel.12219. Epub 2014 Apr 30.

16.

Age-related Deterioration of Hematopoietic Stem Cells.

Kim MJ, Kim MH, Kim SA, Chang JS.

Int J Stem Cells. 2008 Nov;1(1):55-63. Review.

17.

Wnt/β-catenin signaling regulates the proliferation and differentiation of mesenchymal progenitor cells through the p53 pathway.

Peng X, Yang L, Chang H, Dai G, Wang F, Duan X, Guo L, Zhang Y, Chen G.

PLoS One. 2014 May 12;9(5):e97283. doi: 10.1371/journal.pone.0097283. eCollection 2014.

18.

Active transcriptomic and proteomic reprogramming in the C. elegans nucleotide excision repair mutant xpa-1.

Kassahun H, Nilsen H.

Worm. 2013 Oct 1;2(4):e27337. doi: 10.4161/worm.27337. Epub 2013 Dec 5.

19.

The dichotomy of p53 regulation by noncoding RNAs.

Deng Q, Becker L, Ma X, Zhong X, Young K, Ramos K, Li Y.

J Mol Cell Biol. 2014 Jun;6(3):198-205. doi: 10.1093/jmcb/mju017. Epub 2014 Apr 4. Review.

20.

p53 induces skin aging by depleting Blimp1+ sebaceous gland cells.

Kim J, Nakasaki M, Todorova D, Lake B, Yuan CY, Jamora C, Xu Y.

Cell Death Dis. 2014 Mar 27;5:e1141. doi: 10.1038/cddis.2014.87.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk